We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
The Oxford University spinout, launched in 2014, files plans with the SEC to go public on the NASDAQ.
In Q2 2017, Oxford companies raised £93m, OUI was named TTO of the Year, and the £1.2bn contribution to the global economy from Oxford's commercialisation capabilities was highlighted in a new report.
The Oxford University AI company secures £17m as it unveils three AI-driven platforms.
The £13m drug discovery partnership of Oxford University, Evotec and Oxford Sciences Innovation targets five new life sciences projects for acceleration.
As of 2015, OUI has helped create 136 high tech companies based on University intellectual property with a combined turnover of £600m a year, providing 1,886 jobs and adding £132m a year to the local economy.
Scenic Biotech, an international collaboration between Oxford University and Netherlands Cancer Institute, aims to unlock genetic potential in tackling cancer and other diseases with new funding.
Colwiz, a 2013 OUI Incubator company, and Oxford Gene Technology, a spinout 20 years in the making, both make successful trade sales.
Roundup of news, deals, and data from OUI for Q1 2017.
Oxford University and Evotec’s drug discovery partnership launched last year to quickly accelerate drugs to market begins making awards.
Oxford spinout Celleron Therapeutics raises funding from South Korean consortium of investors for small molecule treatments.
